Published 16:03 IST, March 25th 2024
Novo Nordisk acquires Cardior Pharmaceuticals for up to $1.1 billion
The acquisition marks a strategic move for Novo Nordisk, aligning with its objective to broaden its portfolio to include treatments for cardiovascular diseases.
![Novo Nordisk Cardior Pharmaceuticals acquisition](https://img.republicworld.com/tr:w-800,h-450,q-75,f-auto/rimages/istockphoto-logo2-171136283023716_9.webp)
Novo Nordisk Cardior Pharmaceuticals acquisition | Image:
Republic
- Listen to this article
- 1 min read
Advertisement
16:03 IST, March 25th 2024